Citation 127923

KONOSHIMA,T: TAKASAKI,M: KOZUKA,M: NAGAO,T: OKABE,H: IRINO,N: NAKASUMI,T: TOKUDA,H: NISHINO,H:. (1995). INHIBITORY EFFECTS OF CURCURBITANE TRITERPENOIDS ON EPSTEIN-BARR VIRUS ACTIVATION AND TWO-STAGE CARCINOGENENSIS OF SKIN TUMOR. II.. 18(2)

Citation Details

Title	INHIBITORY EFFECTS OF CURCURBITANE TRITERPENOIDS ON EPSTEIN-BARR VIRUS ACTIVATION AND TWO-STAGE CARCINOGENENSIS OF SKIN TUMOR. II.
Authors	KONOSHIMA,T: TAKASAKI,M: KOZUKA,M: NAGAO,T: OKABE,H: IRINO,N: NAKASUMI,T: TOKUDA,H: NISHINO,H:
Year	1995
Volume	18
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Cayaponia tayuya (CUCURBITACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B	None
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B	STRONG ACTIVITY
3	INSECTICIDE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CAYAPONOSIDE B	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-3	None
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-3	STRONG ACTIVITY
6	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE D	None
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE D	STRONG ACTIVITY
8	INSECTICIDE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CAYAPONOSIDE D	WEAK ACTIVITY
9	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE D-3-B	None
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE D-3-B	STRONG ACTIVITY
11	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C-2	None
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C-2	STRONG ACTIVITY
13	INSECTICIDE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CAYAPONOSIDE C-2	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A-6	None
15	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A-6	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C-5-A	None
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C-5-A	WEAK ACTIVITY
18	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C	None
19	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C	WEAK ACTIVITY
20	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A	None
21	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-2	None
23	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-2	WEAK ACTIVITY
24	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE D-1	None
25	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE D-1	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-4	None
27	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-4	ACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A-3	None
29	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A-3	WEAK ACTIVITY
30	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A-4	None
31	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A-4	WEAK ACTIVITY
32	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C-5-B	None
33	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C-5-B	WEAK ACTIVITY
34	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A-5	None
35	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A-5	WEAK ACTIVITY
36	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-5	None
37	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-5	ACTIVE
38	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE D-2	None
39	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE D-2	ACTIVE
40	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C-3	None
41	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C-3	INACTIVE
42	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE A-1	None
43	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE A-1	WEAK ACTIVITY
44	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-6-A	None
45	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-6-A	ACTIVE
46	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE B-6-B	None
47	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE B-6-B	EQUIVOCAL
48	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE D-3-A	None
49	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE D-3-A	ACTIVE
50	Not specified	ISOLATION AND IDENTIFICATION OF	CAYAPONOSIDE C-4	None
51	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAYAPONOSIDE C-4	WEAK ACTIVITY

Citation 127923

Citation Details

Summary

Organisms and Their Experiments (1)

Cayaponia tayuya (CUCURBITACEAE)

Show SPARQL Queries (1)

Query 1